109 related articles for article (PubMed ID: 35304030)
1. Prognostic factors and treatment of relapsed osteosarcoma: A monocentric Tunisian retrospective study.
Ben Kridis W; Ennouri S; Khmiri S; Keskes H; Daoud J; Khanfir A
Arch Pediatr; 2022 May; 29(4):287-291. PubMed ID: 35304030
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?
Palmerini E; Torricelli E; Cascinu S; Pierini M; De Paolis M; Donati D; Cesari M; Longhi A; Abate M; Paioli A; Setola E; Ferrari S
Pediatr Blood Cancer; 2019 Aug; 66(8):e27792. PubMed ID: 31058424
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in High-Grade Localized Osteosarcoma of the Extremities: The Tunisian Experience.
Letaief F; Khrouf S; Yahiaoui Y; Hamdi A; Gabsi A; Ayadi M; Mezlini A
J Orthop Surg (Hong Kong); 2020; 28(3):2309499020974501. PubMed ID: 33283661
[TBL] [Abstract][Full Text] [Related]
4. Surgical resection of relapse may improve postrelapse survival of patients with localized osteosarcoma.
Wong KC; Lee V; Shing MM; Kumta S
Clin Orthop Relat Res; 2013 Mar; 471(3):814-9. PubMed ID: 22972657
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.
Bacci G; Ferrari S; Mercuri M; Bertoni F; Picci P; Manfrini M; Gasbarrini A; Forni C; Cesari M; Campanacci M
Acta Orthop Scand; 1998 Jun; 69(3):230-6. PubMed ID: 9703394
[TBL] [Abstract][Full Text] [Related]
6. Review of management issues in relapsed osteosarcoma.
Vijayamurugan N; Bakhshi S
Expert Rev Anticancer Ther; 2014 Feb; 14(2):151-61. PubMed ID: 24308680
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
[TBL] [Abstract][Full Text] [Related]
8. High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.
Vijayasekharan K; Ramanathan S; Chinnaswamy G; Prasad M; Gulia A; Janu A; Rekhi B; Ramadwar M; Khanna N; Laskar S; Puranadare N; Bajpai J; Puri A; Banavali S; Vora T
J Adolesc Young Adult Oncol; 2021 Apr; 10(2):185-192. PubMed ID: 32706630
[No Abstract] [Full Text] [Related]
9. Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group.
Spraker-Perlman HL; Barkauskas DA; Krailo MD; Meyers PA; Schwartz CL; Doski J; Gorlick R; Janeway KA; Isakoff MS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27444. PubMed ID: 30255612
[TBL] [Abstract][Full Text] [Related]
10. Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review.
Daw NC; Chou AJ; Jaffe N; Rao BN; Billups CA; Rodriguez-Galindo C; Meyers PA; Huh WW
Br J Cancer; 2015 Jan; 112(2):278-82. PubMed ID: 25422914
[TBL] [Abstract][Full Text] [Related]
11. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy.
Bacci G; Ferrari S; Longhi A; Perin S; Forni C; Fabbri N; Salduca N; Versari M; Smith KV
Eur J Cancer; 2001 Jan; 37(1):32-8. PubMed ID: 11165127
[TBL] [Abstract][Full Text] [Related]
12. Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children's Research Hospital experience.
Leary SE; Wozniak AW; Billups CA; Wu J; McPherson V; Neel MD; Rao BN; Daw NC
Cancer; 2013 Jul; 119(14):2645-53. PubMed ID: 23625626
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide and etoposide combination for the treatment of relapsed osteosarcoma.
Akazawa R; Umeda K; Saida S; Kato I; Hiramatsu H; Sakamoto A; Arakawa Y; Sumiyoshi S; Okamoto T; Moritake H; Adachi S; Takita J
Jpn J Clin Oncol; 2020 Aug; 50(8):948-952. PubMed ID: 32463097
[TBL] [Abstract][Full Text] [Related]
14. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V
J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713
[TBL] [Abstract][Full Text] [Related]
15. Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients.
Berger M; Grignani G; Ferrari S; Biasin E; Brach del Prever A; Aliberti S; Saglio F; Aglietta M; Fagioli F
Cancer; 2009 Jul; 115(13):2980-7. PubMed ID: 19452540
[TBL] [Abstract][Full Text] [Related]
16. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution.
Crompton BD; Goldsby RE; Weinberg VK; Feren R; O'Donnell RJ; Ablin AR
Pediatr Blood Cancer; 2006 Sep; 47(3):255-9. PubMed ID: 16123980
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma in patients over 50 years of age: Multi-institutional retrospective analysis of 104 patients.
Nagano A; Matsumoto S; Kawai A; Okuma T; Hiraga H; Matsumoto Y; Nishida Y; Yonemoto T; Hosaka M; Takahashi M; Yoshikawa H; Kunisada T; Asanuma K; Naka N; Emori M; Kubo T; Kawashima H; Kawamoto T; Yokoyama R; Tsukushi S; Sato K; Okamoto T; Hiraoka K; Morioka H; Tanaka K; Takagi T; Iwamoto Y; Ozaki T
J Orthop Sci; 2020 Mar; 25(2):319-323. PubMed ID: 31155441
[TBL] [Abstract][Full Text] [Related]
18. The patterns of relapse in osteosarcoma: the Memorial Sloan-Kettering experience.
Chi SN; Conklin LS; Qin J; Meyers PA; Huvos AG; Healey JH; Gorlick R
Pediatr Blood Cancer; 2004 Jan; 42(1):46-51. PubMed ID: 14752794
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
20. Late relapse in osteosarcoma.
Ferrari S; Briccoli A; Mercuri M; Bertoni F; Cesari M; Longhi A; Bacci G
J Pediatr Hematol Oncol; 2006 Jul; 28(7):418-22. PubMed ID: 16825986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
